Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Observational.
- Who it may be relevant to
- Registry conditions: Staging, Therapeutic Recommendations. Basic parameters: 0 months — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Therapeutic Recommendations for Children Registered in the RFAOP Register and With a Hodgkin Lymphoma
Overview
The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data. Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unites who will adapt these recommendations.
Detailed description
In high-income countries, therapeutic outcomes exceed 90% and therapeutic de-escalation is necessary to reduce mainly the effects of long-term radiotherapy. Within the same country, there are also differences between the therapeutic protocols used in the different centres.
The Experience of Sub-Saharan African Units of the Franco-African Paediatric Oncology Group (GFAOP) in the treatment of pediatric Hodgkin lymphoma in 104 patients was based on chemotherapy alone. The latter was based on COPP/ABV cures without complementary irradiation adapted to the initial stratification and modulated according to the morphological response. Overall survival at 5 years was 82% at 30 months after a median decrease of 17 months.
It seemed appropriate to bring together in a single committee the representatives of the various pilot units in order to standardize the therapeutic protocols in the African countries.
So with this recommendation the GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data.
\- Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unit.
Interventions
- Other Observational
Descriptive data will be collected to evaluation compliance with the protocol and to evaluate outcome
Primary outcome measures
- Patient status [Time frame: 24 months]
- Drugs [Time frame: 24 months]
Eligibility criteria
Inclusion criteria
under 18 years of age at diagnosis
- suffering from "classical" Hodgkin's disease according to the WHO classification.
- with no history of hematological malignancies or constitutional or acquired immune deficiencies
Exclusion criteria
- Over 18 years of age at diagnosis
- A history of hematological malignancies or a history of constitutional or a history of acquired immune deficiencies
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Brenda Mallon — Paris
Identifiers
NCT: NCT05407480 · GFAOP LH 2019